Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368277
Filing Date
2015-11-05
Accepted
2015-11-05 16:09:28
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d92765d10q.htm 10-Q 630982
2 EX-31.1 d92765dex311.htm EX-31.1 7473
3 EX-31.2 d92765dex312.htm EX-31.2 7534
4 EX-32.1 d92765dex321.htm EX-32.1 4401
  Complete submission text file 0001193125-15-368277.txt   2851565

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT xnpt-20150930.xml EX-101.INS 413285
6 XBRL TAXONOMY EXTENSION SCHEMA xnpt-20150930.xsd EX-101.SCH 32060
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xnpt-20150930_cal.xml EX-101.CAL 54592
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xnpt-20150930_def.xml EX-101.DEF 191444
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE xnpt-20150930_lab.xml EX-101.LAB 254183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xnpt-20150930_pre.xml EX-101.PRE 223819
Mailing Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 4086167200
XENOPORT INC (Filer) CIK: 0001130591 (see all company filings)

IRS No.: 943330837 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51329 | Film No.: 151200697
SIC: 2834 Pharmaceutical Preparations